The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology
The need to identify effective therapies for the treatment of psychiatric disorders is a particularly important issue in modern societies. In addition, difficulties in finding new drugs have led pharmacologists to review and re-evaluate some past molecules, including psychedelics. For several years...
Main Authors: | Andrea Mastinu, Margrate Anyanwu, Marinella Carone, Giulia Abate, Sara Anna Bonini, Gregorio Peron, Emanuela Tirelli, Mariachiara Pucci, Giovanni Ribaudo, Erika Oselladore, Marika Premoli, Alessandra Gianoncelli, Daniela Letizia Uberti, Maurizio Memo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/2/1329 |
Similar Items
-
Classic psychedelics do not affect T cell and monocyte immune responses
by: Deborah Rudin, et al.
Published: (2023-01-01) -
Henri Michaux's program for the psychedelic humanities
by: Oliver Davis
Published: (2023-05-01) -
Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders
by: Nataliya Vorobyeva, et al.
Published: (2022-06-01) -
Corrigendum: Three naturally-occurring psychedelics and their significance in the treatment of mental health disorders
by: Nataliya Vorobyeva, et al.
Published: (2023-03-01) -
Hofmann vs. Paracelsus: Do Psychedelics Defy the Basics of Toxicology?—A Systematic Review of the Main Ergolamines, Simple Tryptamines, and Phenylethylamines
by: Luis Alberto Henríquez-Hernández, et al.
Published: (2023-02-01)